Back to results
US 7,608,249 B2Granted
Enhanced substrate imaging by reversible binding to a paramagnetic complex
AssigneeBracco Imaging S.P.A.
InventorsEnzo Terreno, Silvio Aime, Mauro Botta
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for the Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy Imaging of a substrate molecule different from water wherein the NMR signal is enhanced by a reversible binding of the substrate molecule to a paramagnetic chelate complex, as well as to the use of a paramagnetic chelate complex in said method and the pharmaceutical composition for use therein.
Claims10
A method of obtaining images comprising:
- administering a paramagnetic chelate complex comprising a lanthanide metal ion with atomic number ranging from 58 to 70, or a transition metal ion with atomic number from 21 to 29 and from 42 and 44 and a chelating ligand selected from, 10-[(3-methoxyphenyl)methyl]-1,4,7,10-tetraazaciclododecane-1,4,7-tris-[(aminocarbonyl)methyl], and 10-[(3-methoxyphenyl)methyl]-1,4,7,10-tetraazaciclododecane-1,4,7-triacetic acid, or a physiologically acceptable salt thereof, which non covalently binds with a binding strength of at least 10M-1 to a substrate molecule, thereby shortening the relaxation times of the magnetic nuclei of the substrate molecule by forming a non-covalent reversible binding between the substrate and the paramagnetic chelate complex and
- registering the image of the substrate molecule in a human or animal body organ or tissue by use of the Magnetic Resonance Imaging techniques,
- wherein said image is obtained in vivo and
- wherein said substrate molecule is an endogenous substrate selected from lactate, citrate, carbonate, phosphate, pyruvate, natural amino-acids, oxalate, tartrate, succinate, choline, creatine, acetate, and malonate in a human or animal body organ or tissue.
1 more element
A compound which is selected from:
- 10-[(3-methoxyphenyl)methyl]-1,4,7,10-tetraazacyclododecane-1,4,7-tris-[(aminocarbonyl)methyl], the gadolinium complex thereof optionally in form of the ternary complex with citrate, 10-[(3-methoxyphenyl)methyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid and the gadolinium complex thereof.
Dependencies are inferred from the claim text.